Stocks · Health care · Pharmaceutical Preparations

CytomX Therapeutics, Inc.

CTMX Clue Score50
United States Fiscal year ends December CIK 0001501989 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Elaine Jones V
29 Mar 2023
Director
Buy
5,000
$1.55
$7.75K
Lloyd A Rowland
4 Mar 2019
General Counsel
Buy
9,000
$10.33
$92.97K

What was left out

Form 4 filings counted 311
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 53
Sales at will 91
Transactions with no price 0
Shares from compensation/vesting 8,432,272
Sales filed before the plan box existed 59
History held since 9 Oct 2015